Whitehawk Therapeutics (WHWK) EBIT (2010 - 2026)
Whitehawk Therapeutics (WHWK) reported EBIT of -$23.5 million for Q1 2026, down 54.57% year-over-year from -$51.8 million in Q1 2025, and down 127.61% quarter-over-quarter from $85.2 million in Q4 2025.
Whitehawk Therapeutics (WHWK) EBIT (2010 - 2026) Analysis & Trends
Whitehawk Therapeutics (WHWK) has 17 years of EBIT data on file, last reported at -$23.5 million in Q1 2026.
- EBIT for Q1 2026 came in at -$23.5 million, down 54.57% year-over-year; the trailing twelve-month figure through Mar 2026 was -$12.6 million (up 80.01% YoY), and the FY2025 annual result was -$4.3 million, up 93.59% from the prior year.
- EBIT fell to -$23.5 million in Q1 2026 per WHWK's latest filing, from $85.2 million in the prior quarter.
- Over five years, EBIT peaked at $85.2 million in Q4 2025 and troughed at -$54.7 million in Q2 2025.
- A 5-year average of -$13.5 million and a median of -$17.7 million in 2023 frame the typical range for EBIT.
- The sharpest annual moves came in 2022 and 2025: EBIT sank 373.81% in 2022, then jumped 549.56% in 2025.
- A 5-year view of EBIT shows it stood at -$15.5 million in 2022, then decreased by 14.49% to -$17.7 million in 2023, then declined by 6.97% to -$18.9 million in 2024, then jumped by 549.56% to $85.2 million in 2025, then plunged by 127.61% to -$23.5 million in 2026.
- Business Quant data shows WHWK's EBIT at -$23.5 million in Q1 2026, $85.2 million in Q4 2025, and -$19.5 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | -32.68 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -19.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -3.82 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -15.76 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | -1.51 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.14 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -65.83 Mn |
| 10 | Whitehawk Therapeutics | 310.18 Mn | 187.14 Mn | - | -23.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -23.52 Mn |
| Dec 31, 2025 | 85.19 Mn |
| Sep 30, 2025 | -19.55 Mn |
| Jun 30, 2025 | -54.75 Mn |
| Mar 31, 2025 | -15.22 Mn |
| Dec 31, 2024 | -18.95 Mn |
| Sep 30, 2024 | -13.41 Mn |
| Jun 30, 2024 | -15.58 Mn |
| Mar 31, 2024 | -19.51 Mn |
| Dec 31, 2023 | -17.71 Mn |
| Sep 30, 2023 | -17.85 Mn |
| Jun 30, 2023 | -19.55 Mn |
| Mar 31, 2023 | -16.83 Mn |
| Dec 31, 2022 | -15.47 Mn |
| Sep 30, 2022 | -15.04 Mn |
| Jun 30, 2022 | -18.36 Mn |
| Mar 31, 2022 | -13.81 Mn |
| Dec 31, 2021 | -15.95 Mn |
| Sep 30, 2021 | -87.31 Mn |
| Jun 30, 2021 | -3.88 Mn |